Advertisement
Advertisement

SOPH

SOPH logo

SOPHiA GENETICS SA Ordinary Shares

5.17
USD
Sponsored
-0.08
-1.43%
Jan 29, 15:59 UTC -5
Closed
exchange

After-Market

5.17

0.00
0.00%

SOPH Earnings Reports

Positive Surprise Ratio

SOPH beat 10 of 18 last estimates.

56%

Next Report

Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
$20.94M
/
-$0.24
Implied change from Q3 25 (Revenue/ EPS)
+7.57%
/
-14.29%
Implied change from Q4 24 (Revenue/ EPS)
+18.06%
/
+4.35%

SOPHiA GENETICS SA Ordinary Shares earnings per share and revenue

On Nov 04, 2025, SOPH reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.24 USD, resulting in a -13.18% surprise. Revenue reached 19.46 million, compared to an expected 18.49 million, with a 5.27% difference. The market reacted with a -6.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 20.94 million USD, implying an decrease of -14.29% EPS, and increase of 7.57% in Revenue from the last quarter.
FAQ
For Q3 2025, SOPHiA GENETICS SA Ordinary Shares reported EPS of -$0.28, missing estimates by -13.18%, and revenue of $19.46M, 5.27% above expectations.
The stock price moved down -6.4%, changed from $5.00 before the earnings release to $4.68 the day after.
The next earning report is scheduled for Mar 03, 2026.
Based on 6 analysts, SOPHiA GENETICS SA Ordinary Shares is expected to report EPS of -$0.24 and revenue of $20.94M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement